English Chinese
Company Introduction Development History Recruitment Contact Us
Company Introduction

Digital Health China Technologies Co., Ltd.(DHC)is a rapidly growing and prominent international enterprise at the forefront of medical big data and artificial intelligence in the medical industry. Established in the year 2016, DHC is headquartered in Beijing, with subsidiaries located in Boston and Singapore. Guided by the steadfast principle of "Extreme Technology, Infinite Health", DHC places unwavering emphasis on pioneering technologies within the spheres of big data and artificial intelligence. The company is dedicated to delivering cutting-edge products and innovative solutions across the entire medical industry, with the overarching aim of forging a bright and healthy future.

300300 million people
Data Governance
55 +
National Specialized Disease
Data Platforms
4040 +
National Research Topics
and Major National Projects
400400 +
Tertiary Hospitals
18001800 +
Customers from hospitals, public health,
pharmaceutical companies, insurance, etc.
2020 +
Global Strategic Partners
Honors and Qualifications
Beijing Enterprise Technology Center
High-tech Enterprise
High-tech Enterprise in Zhongguancun of Beijing
2020 Ministry of Industry and Information Technology Big Data Industry Development Pilot Demonstration Project Base
2021 Ministry of Industry and Information Technology Big Data Industry Development Pilot Demonstration Project Base
Unicorn Enterprise in Medical Big Data in 2021
Leading Enterprise in Medical AI in 2021
Software Core Competitiveness Enterprise in Beijing
Top 10 medical big data enterprises in China in 2022
Leading enterprises in medical big data and artificial intelligence in 2022
the Best Innovative Application Award of Precision Medical Big Data in 2022
the Best Innovative Application Award for Smart Diagnosis and Treatment
The most industry-leading enterprise in 2023 (healthcare)
Leading innovative digital healthcare enterprises in China in 2023
Development History
  • 2023.9
    The Nanfang Hospital Project, the first hospital-wide multi-modal big data integration research platform in China undertaken by DHCtech, was officially put into use
  • 2023.8
    The China Children's Immune Disease Research Network Platform built by DHCtech was successfully launched
  • 2023.8
    DHCtech, as the unit in charge of the project, was approved for the integration project of biology and information technology of the National Development and Reform Commission, with a total investment of more than 300 million RMB
  • 2023.6
    DHCtech won the title of Leading Innovative Digital Medical Enterprise in China
  • 2023.5
    DHCtech won the Excellent Enterprise of Guangzhou Forum on Medical Informatization
  • 2023.1
    DHCtech won the Best Contribution Award of the first tumor artificial intelligence committee of China Anti-Cancer Association
  • 2022.12
    DHCtech won the TOP10 of 2022 China Medical Big Data Enterprise
  • 2022.12
    DHCtech won the Best Innovative Application Award of Precision Medical Big Data in 2022
  • 2022.11
    DHCtech won 8 national key R&D projects in the 14th Five-Year Plan
  • 2022.9
    DHCtech won the Best Innovative Application Award for Smart Diagnosis and Treatment
  • 2022.7
    DHCtech won the title of Medical Big Data Unicorn Enterprise and Medical Artificial Intelligence Leading Enterprise in 2021
  • 2021.12
    DHCtech was awarded the 2021 Medical Big Data Unicorn Enterprise and Medical Artificial Intelligence Leader
  • 2021.10
    DHCtech builds a multi-center prostate cancer single-case big data platform
  • 2021.7
    DHCtech won the bid for an important smart medical and scientific research project in the northwest region, constructing a project to improve the diagnosis and treatment capacity of Shaanxi Cancer Hospital for difficult diseases, and building a scientific research platform for tumors in Shaanxi Prov
  • 2021.6
    DHCtech Healthcare was awarded CMMI Level 5 certification, marking a new level of strength in software development and project management
  • 2021.4
    DHCtech participated in the National Key Research and Development Program for Active Health and Scientific and Technological Response to Ageing, which was launched
  • 2021.4
    DHCtech won the bid for the Artificial Intelligence Imaging Intelligent Assisted Diagnosis and Decision-making Platform of Nanfang Hospital
  • 2020.10
    At the 83rd China International Medical Equipment Fair (CMEF), DHCtech and Philips jointly launched " ShineFly 3.0"
  • 2020.2
    The company completed Series A+ financing of RMB 2 billion, with strategic investments from SK Group, Tencent, Philips and others
  • 2020.2
    Entrusted by the National Health Commission, the company participated in and completed the national clinical data intelligence processing project for patients with new coronary pneumonia
  • 2019.10
    DHCtech won the first place in the 2019 Artificial Intelligence Assisted Target Area Sketching Competition scored by the experts of the GTV project for lung cancer and the second place overall at the 16th National Conference on Radiation Oncology Therapy of the Chinese Medical Association in 2019
  • 2019.10
    DHCtech won the bid for the project to improve the diagnosis and treatment capacity of difficult diseases in Nanfang Hospital of Southern Medical University
  • 2019.4
    DHCtech joined the Kidney Disease Professional Committee of China Health Information and Health Care Big Data Society, participating in the project led by Nanfang Hospital. Hou Fanfan academician-led research on the medical big data platform for nephrology, exclusively providing the core technology<
  • 2019.3
    A strategic agreement between DHCtech and IQVIA (US headquarters), a world-renowned human life data science company, jointly promoting the development of real-world research in China
  • 2018.12
    DHCtech builds the China Cardiovascular Consortium's national cardiovascular big data platform
  • 2018.11
    AMIA2018 China-US Joint Center for Medical Information and Big Data Science established
  • 2018.11
    DHCtech was listed in Deloitte 2018 China's Stars of Tomorrow
  • 2018.11
    DHCtech was selected as an innovative enterprise of the year in 2018 China's large health industry
  • 2018.10
    China Rare Disease Alliance was established in Beijing, and DHCtech was invited to be the first member of the Alliance
  • 2018.8
    DHCtech acquired Yihao, Herbots and Weishuo, and set up subsidiaries in the US and Singapore to start its global layout
  • 2018.7
    DHCtech completed Series A financing of nearly RMB 1 billion, introducing capitalists such as Guoxin Fund and Sequoia Capital
  • 2018.6
    DHCtech signed a cooperation agreement with the National Cancer Centre and Public Health England, absorbing the experience of building authoritative tumor data platforms from abroad and making every effort to build a big data platform for tumors in China
  • 2018.2
    DHCtech signed a strategic cooperation agreement with UK company Kangjiannike
  • 2017.12
    DHCtech officially joined the OHDSI consortium of institutions
  • 2017.8
    DHCtech doctors passed SNOMED-CT certification
  • 2016.12
    DHCtech undertakes the construction of national tumor data centre and tumor data platform project
  • 2016.11
    DHCtech and Philips, a global medical giant company, engaged in comprehensive and in-depth cooperation in the fields of tumor treatment, medical image processing, breast cancer screening, cardiovascular and cerebrovascular disease treatment, etc.
  • 2016.10
    DHCtech started cooperation with the international top Harvard-MIT Broad Institute and Bio-X researchers from Shanghai Jiaotong University on precision medical big data research
  • 2016.9
    Digital Health China Technologies Co., Ltd. was formally established